Allosterix Pharmaceuticals, LLC

subglobal1 link | subglobal1 link | subglobal1 link | subglobal1 link | subglobal1 link | subglobal1 link | subglobal1 link
subglobal2 link | subglobal2 link | subglobal2 link | subglobal2 link | subglobal2 link | subglobal2 link | subglobal2 link
subglobal3 link | subglobal3 link | subglobal3 link | subglobal3 link | subglobal3 link | subglobal3 link | subglobal3 link
subglobal4 link | subglobal4 link | subglobal4 link | subglobal4 link | subglobal4 link | subglobal4 link | subglobal4 link
subglobal5 link | subglobal5 link | subglobal5 link | subglobal5 link | subglobal5 link | subglobal5 link | subglobal5 link
subglobal6 link | subglobal6 link | subglobal6 link | subglobal6 link | subglobal6 link | subglobal6 link | subglobal6 link
subglobal7 link | subglobal7 link | subglobal7 link | subglobal7 link | subglobal7 link | subglobal7 link | subglobal7 link
subglobal8 link | subglobal8 link | subglobal8 link | subglobal8 link | subglobal8 link | subglobal8 link | subglobal8 link

Team

 

Management:

P. Greg Czyryca, Ph.D., President and Chief Scientific Officer LinkedIn
Master’s degree in Medicinal Chemistry, doctorate in Physical Chemistry. Over 10 years of experience in academia (University of Nebraska in Lincoln, Odense University, Denmark, Technical University of Lodz, Poland, Utah State University), then another 10+ years of industrial experience. Dr. Czyryca specializes in computer-aided drug discovery, and is responsible for research and business development.

Scientific Advisors:

Joseph K. -K. Li, Ph.D., Professor, Utah State University, Department of Biology and Institute for Antiviral Research

Piotr Paneth, D. Sc., Professor, Department of Chemistry, Technical University of Lodz, Poland

Page by PGC

Free Web Hosting